Australia markets open in 1 hour 18 minutes

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1100-0.0100 (-0.89%)
At close: 01:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.06M
Enterprise value -18.13M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.12
Price/book (mrq)0.09
Enterprise value/revenue -0.53
Enterprise value/EBITDA 1.75

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-67.54%
S&P500 52-week change 318.92%
52-week high 312.4800
52-week low 31.1040
50-day moving average 31.6382
200-day moving average 33.9284

Share statistics

Avg vol (3-month) 334.85k
Avg vol (10-day) 35.05k
Shares outstanding 53.62M
Implied shares outstanding 63.62M
Float 81.56M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (30 Aug 2023) 438.26k
Short ratio (30 Aug 2023) 40.74
Short % of float (30 Aug 2023) 42.48%
Short % of shares outstanding (30 Aug 2023) 41.06%
Shares short (prior month 30 July 2023) 49.32k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 327 July 2023

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin -32.50%
Operating margin (ttm)-29.04%

Management effectiveness

Return on assets (ttm)-8.81%
Return on equity (ttm)-20.66%

Income statement

Revenue (ttm)34.41M
Revenue per share (ttm)9.49
Quarterly revenue growth (yoy)-23.70%
Gross profit (ttm)21.89M
Net income avi to common (ttm)-11.18M
Diluted EPS (ttm)-2.5100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.27M
Total cash per share (mrq)7.25
Total debt (mrq)4.08M
Total debt/equity (mrq)8.65%
Current ratio (mrq)2.26
Book value per share (mrq)13.00

Cash flow statement

Operating cash flow (ttm)-2.63M
Levered free cash flow (ttm)3.99M